EU recommends Roche’s Avastin plus chemotherapy to treat cervical cancer

The European Union's (EU) Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Avastin (bevacizumab) in combination with standard chemotherapy (paclitaxel and cisplatin or paclitaxel and topotecan in patients who cannot re…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news